Compare RLAY & WAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RLAY | WAY |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.8B |
| IPO Year | 2020 | 2023 |
| Metric | RLAY | WAY |
|---|---|---|
| Price | $18.66 | $23.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 17 |
| Target Price | $19.50 | ★ $36.59 |
| AVG Volume (30 Days) | ★ 2.2M | 2.0M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.78 | ★ 569.23 |
| EPS | N/A | ★ 0.43 |
| Revenue | $15,355,000.00 | ★ $1,099,278,000.00 |
| Revenue This Year | N/A | $18.26 |
| Revenue Next Year | $324.03 | $10.62 |
| P/E Ratio | ★ N/A | $56.37 |
| Revenue Growth | ★ 53.44 | 16.50 |
| 52 Week Low | $3.89 | $17.26 |
| 52 Week High | $21.27 | $39.99 |
| Indicator | RLAY | WAY |
|---|---|---|
| Relative Strength Index (RSI) | 45.13 | 44.40 |
| Support Level | $18.00 | $23.65 |
| Resistance Level | $20.82 | $24.67 |
| Average True Range (ATR) | 0.80 | 1.02 |
| MACD | -0.13 | -0.24 |
| Stochastic Oscillator | 28.24 | 7.04 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. Its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.